You have no items in your shopping cart.
On Promotion
Species Host
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 359PE 42FITC 40APC 36Biotin 31PE/Cy7 20Cy3 19APC/Cy7 17HRP 17PE/Cy5 17Cy5 15Pacific Blue 14PerCP 14PerCP/Cy5.5 14APC/Cy5.5 13BF350 12BF405 12BF488 12BF555 12BF594 12BF647 12BF680 12BF700 12BF750 12Cy5.5 12Cy7 12PE/Cy5.5 12PerCP/Cy7 12RBITC 12AP 8Carrier-free 4Fluoro488 4Fluoro550 4Fluoro594 4Fluoro647 4IRDye800 2
Biologically Active
Featured Product
Search results for: 'c-kit'
Motesanib [orb1305790]98.00% (May vary between batches)
453562-69-1
373.45
C22H23N5O
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.36 mM);DMSO:50 mg/mL (133.89 mM)
12 months from date of receipt.
1 ml x 10 mM (in DMSO), 100 mg, 25 mg, 500 mg, 200 mg, 10 mg, 50 mg, 5 mg- Agerafenib [orb1306565]
95.78% (May vary between batches)
1188910-76-0
517.46
C24H22F3N5O5
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.87 mM);Ethanol:< 1 mg/mL (insoluble or slightly soluble);DMSO:45 mg/mL (86.96 mM)
12 months from date of receipt.
1 ml x 10 mM (in DMSO), 200 mg, 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg 
Human KITLG protein [orb392027]ELISA, MS, SDS-PAGE, WB
Greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE.
E. coli
10 μg, 50 μg, 500 μg- Human KITLG protein [orb392028]
ELISA, MS, SDS-PAGE, WB
Greater than 95% as determined by reducing SDS-PAGE.
Human cells
10 μg, 50 μg, 500 μg - Mouse KITLG protein [orb392029]
ELISA, MS, SDS-PAGE, WB
Greater than 95% as determined by reducing SDS-PAGE.
E. coli
10 μg, 50 μg, 500 μg - Dovitinib lactate [orb1300069]
98.44% (May vary between batches)
692737-80-7
482.51
C24H27FN6O4
DMSO:25 mg/mL (51.81 mM)
12 months from date of receipt.
1 ml x 10 mM (in DMSO), 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg - Dovitinib lactate hydrate [orb1300733]
99.17% (May vary between batches)
915769-50-5
482.51
C24H27FN6O4
H2O:61 mg/mL (126.42 mM);Ethanol:1 mg/mL (2.07 mM);DMSO:13.89 mg/mL (28.79 mM)
12 months from date of receipt.
1 ml x 10 mM (in DMSO), 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg - Bafetinib [orb1300879]
94.16% (May vary between batches)
859212-16-1
576.62
C30H31F3N8O
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.72 mM);H2O:< 1 mg/mL (insoluble or slightly soluble);DMSO:120 mg/mL (208.11 mM);Ethanol:< 1 mg/mL (insoluble or slightly soluble)
12 months from date of receipt.
1 ml x 10 mM (in DMSO), 2 mg, 5 mg, 1 mg, 25 mg, 10 mg, 50 mg, 100 mg, 200 mg - OSI-930 [orb1305252]
99.67% (May vary between batches)
728033-96-3
443.44
C22H16F3N3O2S
DMSO:82 mg/mL (184.92 mM);Ethanol:3 mg/mL (6.77 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.44 mM)
12 months from date of receipt.
10 mg, 1 mg, 1 ml x 10 mM (in DMSO), 5 mg, 25 mg, 50 mg, 100 mg - Masitinib [orb1305268]
97.56% (May vary between batches)
790299-79-5
498.64
C28H30N6OS
H2O:< 1 mg/mL (insoluble or slightly soluble);DMSO:250 mg/mL (501.36 mM);Ethanol:4 mg/mL (8.02 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.01 mM)
12 months from date of receipt.
1 ml x 10 mM (in DMSO), 25 mg, 500 mg, 50 mg, 100 mg